ARTICLE | Company News
Exelixis, Swedish Orphan Biovitrum sales and marketing update
March 4, 2013 8:00 AM UTC
Exelixis granted Swedish Orphan rights to distribute and commercialize Cometriq cabozantinib to treat metastatic medullary thyroid cancer (MTC) in the EU, Switzerland, Norway, Russia, Turkey and cert...